Skip to main navigation Skip to search Skip to main content

Phenotypic variability in familial hypercholesterolaemia: an update

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Heterozygous familial hypercholesterolaemia is among the most common inherited dominant disorders, and is characterized by severely elevated LDL-cholesterol levels and premature cardiovascular disease. Although the cause of familial hypercholesterolaemia is monogenic, there is a substantial variation in the onset and severity of atherosclerotic disease symptoms. Additional atherogenic risk factors of environmental, metabolic and genetic origin, in conjunction with the LDL receptor defect, are presumed to influence the clinical phenotype in familial hypercholesterolaemia. The present review discusses recent developments in this field. Curr Opin Lipidol 13:165-171. (C) 2002 Lippincott Williams Wilkins
Original languageEnglish
Pages (from-to)165-171
JournalCurrent opinion in lipidology
Volume13
Issue number2
DOIs
Publication statusPublished - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Phenotypic variability in familial hypercholesterolaemia: an update'. Together they form a unique fingerprint.

Cite this